Evidence map›Paper›PMID 32560168›Full record

ArticleInternational journal of environmental research and public health2020

Syndromic Surveillance of Acute Gastroenteritis Using the French Health Insurance Database: Discriminatory Algorithm and Drug Prescription Practices Evaluations.

Frederic Bounoure, Damien Mouly, Pascal Beaudeau, Malek Bentayeb, Julie Chesneau, Gabrielle Jones, Mohamed Skiba, Malika Lahiani-Skiba, Catherine Galey

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Implementation of a national waterborne disease outbreak surveillance system: overview and preliminary results, France, 2010 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Frederic BounoureLaboratory of Pharmaceutical & Biopharmaceutical Technology, UFR of Health, Normandy University, Unirouen, 22 Bd Gambetta, 76183 Rouen Cedex, France.
Damien MoulySanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.
Pascal BeaudeauSanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.
Malek BentayebSanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.ORCID 0000-0001-7205-046X
Julie ChesneauSanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.
Gabrielle JonesSanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.
Mohamed SkibaLaboratory of Pharmaceutical & Biopharmaceutical Technology, UFR of Health, Normandy University, Unirouen, 22 Bd Gambetta, 76183 Rouen Cedex, France.ORCID 0000-0002-0360-7743
Malika Lahiani-SkibaLaboratory of Pharmaceutical & Biopharmaceutical Technology, UFR of Health, Normandy University, Unirouen, 22 Bd Gambetta, 76183 Rouen Cedex, France.
Catherine GaleySanté Publique France, French National Public Health Agency, F-94415 Saint-Maurice, France.ORCID 0000-0001-7729-325X
Santé Publique France · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The French national public health agency (Santé publique France) has used data from the national health insurance reimbursement system (SNDS) to identify medicalised acute gastroenteritis (mAGE) for more than 10 years. This paper presents the method developed to evaluate this system: performance and characteristics of the discriminatory algorithm, portability in mainland and overseas French departments, and verification of the mAGE database updating process. Pharmacy surveys with certified mAGE from 2012 to 2015 were used to characterise mAGE and to estimate the sensitivity and predictive positive value (PPV) of the algorithm. Prescription characteristics from these pharmacy surveys and from 2014 SNDS prescriptions in six mainland and overseas departments were compared. The sensitivity (0.90) and PPV (0.82) did not vary according to the age of the population or year. Prescription characteristics were similar within all studied departments. This confirms that the algorithm can be used in all French departments, for both paediatric and adult populations, with stability and durability over time. The algorithm can identify mAGE cases at a municipal level. The validated system has been implemented in a national waterborne disease outbreaks surveillance system since 2019 with the aim of improving the prevention of infectious disease risk attributable to localised tap water systems.

Indexed as

GastroenteritisInsurance, HealthSentinel SurveillanceAdolescentAdultAlgorithmsChildChild, PreschoolDrug PrescriptionsFranceHumansPopulation Surveillanceacute gastroenteritisdrug prescriptionFrancehealth insurance reimbursement databasepharmacy surveysyndromic surveillancewaterborne outbreak

Identifiers

PMID32560168
PMCPMC7345322
OpenAlexW3035495048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.